| Literature DB >> 34096310 |
Mohammad Mahmoudzadeh1, Aniket Magarkar2, Artturi Koivuniemi1, Tomasz Róg3, Alex Bunker3.
Abstract
Liposome-based drug delivery systems composed of DOPE stabilized with cholesteryl hemisuccinate (CHMS) have been proposed as a drug delivery mechanism with pH-triggered release as the anionic form (CHSa) is protonated (CHS) at reduced pH; PEGylation is known to decrease this pH sensitivity. In this manuscript, we set out to use molecular dynamics (MD) simulations with a model with all-atom resolution to provide insight into why incorporation of poly(ethyleneglycol) (PEG) into DOPE-CHMS liposomes reduces their pH sensitivity; we also address two additional questions: (1) How CHSa stabilizes DOPE bilayers into a lamellar conformation at a physiological pH of 7.4? and (2) how the change from CHSa to CHS at acidic pH triggers the destabilization of DOPE bilayers? We found that (A) CHSa stabilizes the DOPE lipid membrane by increasing the hydrophilicity of the bilayer surface, (B) when CHSa changes to CHS by pH reduction, DOPE bilayers are destabilized due to a reduction in bilayer hydrophilicity and a reduction in the area per lipid, and (C) PEG stabilizes DOPE bilayers into the lamellar phase, thus reducing the pH sensitivity of the liposomes by increasing the area per lipid through penetration into the bilayer, which is our main focus.Entities:
Keywords: PEGylated pH-sensitive liposomes; bilayer hydrophilicity; cholesteryl hemisuccinate; molecular dynamics simulations; phase transition
Mesh:
Substances:
Year: 2021 PMID: 34096310 PMCID: PMC8289284 DOI: 10.1021/acs.molpharmaceut.1c00122
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939
Detailed Description of the Composition of All of the Six Simulated Systems
| system abbreviation | DOPE | CHOL | CHS | CHSa | PEG | Na+ | Cl– | K+ | water | MD length (ns) |
|---|---|---|---|---|---|---|---|---|---|---|
| DOPE–CHOL | 192 | 96 | 0 | 0 | 0 | 30 | 30 | 0 | 12 140 | 300 |
| DOPE–CHS | 192 | 0 | 96 | 0 | 0 | 30 | 30 | 0 | 12 140 | 300 |
| DOPE–CHSa | 192 | 0 | 0 | 96 | 0 | 30 | 30 | 96 | 12 044 | 300 |
| PEG–DOPE–CHOL | 192 | 96 | 0 | 0 | 14 | 70 | 70 | 14 | 30 144 | 400 |
| PEG–DOPE–CHS | 192 | 0 | 96 | 0 | 14 | 70 | 70 | 14 | 30 144 | 400 |
| PEG–DOPE–CHSa | 192 | 0 | 0 | 96 | 14 | 70 | 70 | 110 | 30 048 | 400 |
Figure 1Chemical structure of the components of the bilayer showing atom numbering for the acyl chains of DOPE and the partial charges derived for CHOL, CHS, and CHSa.
Figure 2Average area per molecule.
Figure 3Partial mass density profiles of water relative to the position of the phosphate head group peak (A). Number of bilayer–water contacts (shown in bar graphs with values on the left-hand side Y-axis) and number of bilayer–water H-bonds (in line graphs with values on the right-hand side Y-axis) (B). Percentage of area of the steroid head groups covered by other components of the system (C).
Number of Bilayer–PEG, Interlipid, and Lipid–Steroid H-Bonds
| system name | DOPE–DOPE | DOPE–steroid | bilayer–PEG |
|---|---|---|---|
| DOPE–CHOL | 78.82 ± 8.91 | 32.95 ± 4.56 | |
| DOPE–CHS | 91.02 ± 7.92 | 57.52 ± 4.95 | |
| DOPE–CHSa | 93.08 ± 8.37 | 75.83 ± 5.43 | |
| PEG–DOPE–CHOL | 81.11 ± 7.28 | 33.74 ± 4.20 | 13.25 ± 6.08 |
| PEG–DOPE–CHS | 92.38 ± 8.17 | 56.82 ± 5.03 | 26.71 ± 4.10 |
| PEG–DOPE–CHSa | 88.86 ± 7.72 | 66.51 ± 5.66 | 14.71 ± 3.13 |
Figure 4Deuterium order parameter along the Sn-1 tail (A) and mass density profile results for the lipid component (B).
Figure 5Percentage of Na+ ions in contact with the bilayers in non-PEGylated systems (A) and percentage of Na+ ions in contact with the bilayers and PEG chains of the PEGylated systems (B).
Figure 6Mass density profile of PEG relative to the position of the phosphate head group peak (A) and visualization of the final configurations of the system in the last frame of the simulation of PEG–DOPE–CHOL (B), PEG–DOPE–CHS(C), and PEG–DOPE–CHSa (D). Phosphate atoms are colored as green and PEG chains as red. All other components of the systems were removed for clarity. The inset in Figure A represents the PEG mass density profile of PEG5%–DSPC–CHOL33% studied in our previous publication (ref (44)).